Overview
Alan Merry is a Nurse Practitioner in Canton, Ohio. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Smoldering Multiple Myeloma, and Heart Failure with Preserved Ejection Fraction (HFpEF). Mr. Merry is currently accepting new patients.
His clinical research consists of co-authoring 172 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- PPO
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE PART D
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
Locations
2600 6th St Sw, Canton, OH 44710
Tara Plues is a Nurse Practitioner in Cleveland, Ohio. Ms. Plues is highly rated in 1 condition, according to our data. Her top area of expertise is ALK-Positive Non-Small Cell Lung Cancer.
Cleveland Clinic
Beth Mellors is a Nurse Practitioner specialist and a Neurologist in Cleveland, Ohio. Ms. Mellors is highly rated in 40 conditions, according to our data. Her top areas of expertise are Meningioma, Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, and Metastatic Brain Tumor.
Tina Alsept is a Nurse Practitioner in Dover, Ohio. Ms. Alsept is highly rated in 3 conditions, according to our data. Her top areas of expertise are Boils, Folliculitis, and Carbuncle. Ms. Alsept is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer
- Heart Failure with Preserved Ejection Fraction (HFpEF)
- Smoldering Multiple MyelomaMr. Merry isExperienced. Learn about Smoldering Multiple Myeloma.